Building a European innovation platform for the repurposing of medicinal products
The 'Building a European innovation platform for the repurposing of medicinal products' program, identified as HORIZON-HLTH-2021-DISEASE-04-02, aims to establish a robust and sustainable platform to accelerate the repurposing of existing medicinal products. This initiative seeks to significantly reduce the time and cost associated with drug development, offering new and cost-effective therapeutic options for unmet medical needs across various diseases. It uniquely fosters collaboration between the public sector, pharmaceutical industry, and other key stakeholders at a European and international level.
Who is Funded for Medicinal Product Repurposing
This section outlines the eligibility criteria for applicants, the geographical scope of the program, and its core objectives. The program seeks to fund a wide array of entities across Europe, associated countries, and the USA, all working towards establishing a leading European platform for medicinal product repurposing.
What is Funded in Medicinal Product Repurposing
This section details the types of projects and thematic areas supported, emphasizing the development of a comprehensive platform for drug repurposing. The focus is on innovative approaches, data leveraging, and collaborative networks within the health sector.
Type and Scope of Funding for European Innovation Platform
This section outlines the financial aspects of the program, including the type of financial support, available funding amounts, and project duration. The program primarily offers grants with substantial funding per project.
Conditions and Requirements for Applicants
This section details the critical conditions and requirements for applicants, spanning administrative stipulations, consortium guidelines, and other important provisions that govern participation and project implementation.
Application Procedure Overview
This section outlines the application timeline and evaluation process for the funding program. The call is now closed, with evaluation results already communicated.
Legal Basis of the Funding Program
This section identifies the foundational legal and official documents that govern the program, providing transparency on its mandate and operational framework. These documents are primarily from the Horizon Europe framework, ensuring adherence to EU regulations.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
25,000,000 €
Allocated Budget:
50,000,000 €
Deadline:
21.09.2021
Open Until:
Ongoing
Award Channel:
Framework Programme Call
Region:
European Union, Associated Countries, United States of America. International cooperation is encouraged.
Sectors:
Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Information and Communication Technology, Service Sector, Other
Beneficiaries:
Health, pharmaceutical industry
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction, Commercialization
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Commission (under Horizon Europe)
Additional Partners:
No specific additional partners are named, but cooperation between EU-funded projects (Horizon Europe, EU4Health Programme, other clusters/pillars) is welcomed and supported for cross-fertilisation and synergies.
Website: